Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

N-[2,6-bis(1-methylethyl)phenyl]-Ní-[[1-[4-(dimethylamino) phenyl]cyclopentyl]methyl]urea, hydrochloride salt

EU orphan designation number: EU/3/13/1128   
Active ingredient: N-[2,6-bis(1-methylethyl)phenyl]-Ní-[[1-[4-(dimethylamino) phenyl]cyclopentyl]methyl]urea, hydrochloride salt
Indication: Treatment of adrenocortical carcinoma
Sponsor: Atterocor Ltd
20-22 Bedford Row, London, WC1R 4JS, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2013 Centralised Orphan - Designation EMA/OD/195/12 (2013)3664 of 07/06/2013